vs

Side-by-side financial comparison of Delek US Holdings, Inc. (DK) and Steris (STE). Click either name above to swap in a different company.

Delek US Holdings, Inc. is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× Steris). Steris runs the higher net margin — 12.9% vs 3.2%, a 9.7% gap on every dollar of revenue. On growth, Steris posted the faster year-over-year revenue change (9.2% vs 2.3%). Delek US Holdings, Inc. produced more free cash flow last quarter ($382.8M vs $199.5M). Over the past eight quarters, Steris's revenue compounded faster (15.8% CAGR vs -11.9%).

Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.

Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018.

DK vs STE — Head-to-Head

Bigger by revenue
DK
DK
1.6× larger
DK
$2.4B
$1.5B
STE
Growing faster (revenue YoY)
STE
STE
+6.8% gap
STE
9.2%
2.3%
DK
Higher net margin
STE
STE
9.7% more per $
STE
12.9%
3.2%
DK
More free cash flow
DK
DK
$183.3M more FCF
DK
$382.8M
$199.5M
STE
Faster 2-yr revenue CAGR
STE
STE
Annualised
STE
15.8%
-11.9%
DK

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
DK
DK
STE
STE
Revenue
$2.4B
$1.5B
Net Profit
$78.3M
$192.9M
Gross Margin
9.3%
43.8%
Operating Margin
6.8%
18.3%
Net Margin
3.2%
12.9%
Revenue YoY
2.3%
9.2%
Net Profit YoY
118.9%
11.2%
EPS (diluted)
$1.23
$1.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DK
DK
STE
STE
Q4 25
$2.4B
$1.5B
Q3 25
$2.9B
$1.5B
Q2 25
$2.8B
$1.4B
Q1 25
$2.6B
$1.5B
Q4 24
$2.4B
$1.4B
Q3 24
$3.0B
$1.3B
Q2 24
$3.3B
$1.3B
Q1 24
$3.1B
$1.1B
Net Profit
DK
DK
STE
STE
Q4 25
$78.3M
$192.9M
Q3 25
$178.0M
$191.9M
Q2 25
$-106.4M
$177.4M
Q1 25
$-172.7M
$145.7M
Q4 24
$-413.8M
$173.5M
Q3 24
$-76.8M
$150.0M
Q2 24
$-37.2M
$145.4M
Q1 24
$-32.6M
$-1.4M
Gross Margin
DK
DK
STE
STE
Q4 25
9.3%
43.8%
Q3 25
13.8%
44.2%
Q2 25
1.9%
45.1%
Q1 25
-2.4%
43.3%
Q4 24
-5.7%
44.5%
Q3 24
-0.7%
43.6%
Q2 24
0.5%
44.7%
Q1 24
3.0%
40.2%
Operating Margin
DK
DK
STE
STE
Q4 25
6.8%
18.3%
Q3 25
10.2%
18.2%
Q2 25
-1.2%
17.7%
Q1 25
-4.8%
14.6%
Q4 24
-17.0%
17.9%
Q3 24
-4.0%
16.5%
Q2 24
0.1%
14.5%
Q1 24
0.9%
22.0%
Net Margin
DK
DK
STE
STE
Q4 25
3.2%
12.9%
Q3 25
6.2%
13.1%
Q2 25
-3.8%
12.8%
Q1 25
-6.5%
9.8%
Q4 24
-17.4%
12.7%
Q3 24
-2.5%
11.3%
Q2 24
-1.1%
11.4%
Q1 24
-1.0%
-0.1%
EPS (diluted)
DK
DK
STE
STE
Q4 25
$1.23
$1.96
Q3 25
$2.93
$1.94
Q2 25
$-1.76
$1.79
Q1 25
$-2.78
$1.48
Q4 24
$-6.48
$1.75
Q3 24
$-1.20
$1.51
Q2 24
$-0.58
$1.46
Q1 24
$-0.51
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DK
DK
STE
STE
Cash + ST InvestmentsLiquidity on hand
$625.8M
$423.7M
Total DebtLower is stronger
$3.2B
$1.9B
Stockholders' EquityBook value
$547.3M
$7.2B
Total Assets
$6.8B
$10.6B
Debt / EquityLower = less leverage
5.91×
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DK
DK
STE
STE
Q4 25
$625.8M
$423.7M
Q3 25
$630.9M
$319.2M
Q2 25
$615.5M
$279.7M
Q1 25
$623.8M
$171.7M
Q4 24
$735.6M
$155.2M
Q3 24
$1.0B
$172.2M
Q2 24
$657.9M
$198.3M
Q1 24
$753.4M
$207.0M
Total Debt
DK
DK
STE
STE
Q4 25
$3.2B
$1.9B
Q3 25
$3.2B
$1.9B
Q2 25
$3.1B
$1.9B
Q1 25
$3.0B
$1.9B
Q4 24
$2.8B
$2.0B
Q3 24
$2.8B
$2.2B
Q2 24
$2.5B
$2.2B
Q1 24
$2.5B
$3.1B
Stockholders' Equity
DK
DK
STE
STE
Q4 25
$547.3M
$7.2B
Q3 25
$444.8M
$7.0B
Q2 25
$294.9M
$7.0B
Q1 25
$429.4M
$6.6B
Q4 24
$575.2M
$6.4B
Q3 24
$875.4M
$6.6B
Q2 24
$982.8M
$6.4B
Q1 24
$1.0B
$6.3B
Total Assets
DK
DK
STE
STE
Q4 25
$6.8B
$10.6B
Q3 25
$7.1B
$10.4B
Q2 25
$7.1B
$10.4B
Q1 25
$6.9B
$10.1B
Q4 24
$6.7B
$10.0B
Q3 24
$7.0B
$10.2B
Q2 24
$6.9B
$10.1B
Q1 24
$7.2B
$11.1B
Debt / Equity
DK
DK
STE
STE
Q4 25
5.91×
0.27×
Q3 25
7.14×
0.27×
Q2 25
10.51×
0.27×
Q1 25
7.07×
0.29×
Q4 24
4.81×
0.32×
Q3 24
3.19×
0.33×
Q2 24
2.50×
0.35×
Q1 24
2.41×
0.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DK
DK
STE
STE
Operating Cash FlowLast quarter
$502.8M
$298.2M
Free Cash FlowOCF − Capex
$382.8M
$199.5M
FCF MarginFCF / Revenue
15.8%
13.3%
Capex IntensityCapex / Revenue
4.9%
6.6%
Cash ConversionOCF / Net Profit
6.42×
1.55×
TTM Free Cash FlowTrailing 4 quarters
$6.3M
$917.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DK
DK
STE
STE
Q4 25
$502.8M
$298.2M
Q3 25
$44.0M
$287.8M
Q2 25
$51.4M
$420.0M
Q1 25
$-62.4M
$260.8M
Q4 24
$-163.5M
$332.8M
Q3 24
$-21.6M
$250.7M
Q2 24
$-48.4M
$303.7M
Q1 24
$166.7M
$254.8M
Free Cash Flow
DK
DK
STE
STE
Q4 25
$382.8M
$199.5M
Q3 25
$-64.0M
$201.3M
Q2 25
$-114.4M
$326.4M
Q1 25
$-198.1M
$189.9M
Q4 24
$-354.0M
$243.6M
Q3 24
$-140.6M
$148.8M
Q2 24
$-128.3M
$195.7M
Q1 24
$128.4M
$163.3M
FCF Margin
DK
DK
STE
STE
Q4 25
15.8%
13.3%
Q3 25
-2.2%
13.8%
Q2 25
-4.1%
23.5%
Q1 25
-7.5%
12.8%
Q4 24
-14.9%
17.8%
Q3 24
-4.6%
11.2%
Q2 24
-3.9%
15.3%
Q1 24
4.1%
14.6%
Capex Intensity
DK
DK
STE
STE
Q4 25
4.9%
6.6%
Q3 25
3.7%
5.9%
Q2 25
6.0%
6.7%
Q1 25
5.1%
4.8%
Q4 24
8.0%
6.5%
Q3 24
3.9%
7.7%
Q2 24
2.4%
8.4%
Q1 24
1.2%
8.2%
Cash Conversion
DK
DK
STE
STE
Q4 25
6.42×
1.55×
Q3 25
0.25×
1.50×
Q2 25
2.37×
Q1 25
1.79×
Q4 24
1.92×
Q3 24
1.67×
Q2 24
2.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DK
DK

Refining$2.2B91%
Other$173.0M7%
Gravity Water Intermediate Holdings LLC Gravity$22.5M1%
Related Party$20.8M1%
Logistics$1.3M0%

STE
STE

Servicerevenues$404.7M27%
Consumablerevenues$387.1M26%
Applied Sterilization Technologies$286.6M19%
Capitalequipmentrevenues$272.1M18%
Life Science$145.8M10%

Related Comparisons